Regulatory 2020-05-20 | Updated SPARKLE timelines due to Covid-19 impact PDF Report Presentation Webcast
Regulatory 2020-05-06 | First participant enrolled in the clinical hepatic impairment study with Mangoral PDF Report Presentation Webcast
Regulatory 2020-02-19 | First patient enrolled in pivotal Phase III clinical study SPARKLE with lead candidate Mangoral PDF Report Presentation Webcast
Regulatory 2019-06-10 | Ascelia Pharma strengthens its Mangoral franchise by filing of a patent application for next generation Mangoral product PDF Report Presentation Webcast
Regulatory 2019-05-07 | Ascelia Pharma received supportive feedback from EMA on the phase 3 program for Mangoral® PDF Report Presentation Webcast
Regulatory 2019-04-12 | Exercise of over-allotment option, stabilisation notice and end of the stabilisation period PDF Report Presentation Webcast
Regulatory 2019-04-08 | Encouraging results from the Phase I combination study with Oncoral and oral capecitabine published in the journal Cancer Chemotherapy and Pharmacology PDF Report Presentation Webcast
Regulatory 2019-03-12 | Trading in Ascelia Pharma’s shares on Nasdaq Stockholm commences tomorrow PDF Report Presentation Webcast
